BRTX - BioRestorative Therapies Inc logo

BioRestorative Therapies Inc

BRTX

BioRestorative Therapies develops therapeutic products and medical therapies using adult stem cells, focusing on treatments for disc/spine diseases and metabolic disorders, particularly through BRTX-100 and ThermoStem, targeting chronic pain and obesity.

โš•๏ธ Healthcare NASDAQ Listed 2007 $ USD
$1,000 invested 20 years ago โ†’$0today

Score Overview

1 Year
Score
Net Growth22.37%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth-0.51%
Rev TrendShrank
Revenue Consistencyโ€”
5 Years
Score6.9
Net Growth75.04%
Net Trend80%
Net Income Consistencyโ€”
Rev Growth7x
Rev Trend60%
Revenue Consistencyโ€”
10 Years
Score
Net Growth-28.02%
Net Trend50%
Net Income Consistency
Rev Growth9x
Rev Trend60%
Revenue Consistency
All Time
Scoreโ€”
Net Growthโ€”
Net Trend44%
Net Income Consistency
Rev Growthโ€”
Rev Trend58%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where BioRestorative Therapies Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by Net Income Consistency.

Has not reached the top 50 on Net Income Consistency in any year we have ranked.

  • BRTX

2019: 91.5% ยท 2021: 99.4% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-23
$ 1.62โ€”
1 Year2025-10-23
$ 1.572.86%
5 Years2021-10-22
$ 12.80-87.34%
10 Years2016-10-21
$ 13.6K-99.99%
20 Years2006-10-23
$ 1000K-100.00%
All Time2007-07-27
$ 1000K-100.00%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 357.87K-$ 11M$ 3M
2025$ 359.7K-$ 14M$ 2M
2024$ 401K-$ 8M$ 10M
2023$ 145.8K-$ 10M$ 11M
2022$ 119.8K-$ 13M$ 14M
2021$ 46K-$ 44M$ 21M
2020$ 77K-$ 11M$ 3M
2019$ 130K-$ 14M$ 1.66K
2018$ 111K-$ 12M$ 117.52K
2017$ 81K-$ 9M$ 451.68K
2016$ 36.35K-$ 8M$ 31.82K
2015$ 628.91K-$ 7M$ 166.56K
2014$ 416K-$ 5M$ 91.8K
2013-$ 5M$ 201.1K
2012$ 15.59K-$ 6M$ 363.00
2011-$ 4M$ 71.51K
2010-$ 2M$ 18.07K
2009
BRTX - BioRestorative Therapies Inc logo

BioRestorative Therapies Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 77K to $ 359.7K and net income went from -$ 11M to -$ 14M. Revenue increased in 3 of those 5 years; net income in 4.

Between 2015 and 2025, revenue declined from $ 628.91K to $ 359.7K and net income went from -$ 7M to -$ 14M. Revenue increased in 6 of those 10 years; net income in 5.

BioRestorative Therapies Inc currently holds a 5-year HDB Score of 6.9 out of 10. How the HDB Score is calculated.

Membership

Continue BRTXโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,112 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies